BrandWikiReturn

BoxGroup

BoxGroup is an investment fund company based in New York City.[1] It was founded in 2007 by David Tisch.

Company History

BoxGroup was founded in 2007 by David Tisch, grandson of entrepreneur Laurence A. Tisch, and Adam Rothenberg.[2]

BoxGroup invests in the pre-seed and seed rounds of financing for early-stage companies. One of the financing companies they have invested in is Ramp (company), a corporate card start-up. [3] The venture capital fund invests in start-up technology businesses in many sectors, including marketplaces, e-commerce, SAAS, and financial tech.[1][4][5]

In October 2019, BoxGroup closed two external LP-backed funds totaling $165 million.[6]

BoxGroup was among the top three most active United States–based micro venture capital firms in 2014.[7]

In 2025, BoxGroup raised $550 million across two new funds.[8]

Investments

The company has more than 230 investments in startup companies, including Ramp, Vine, Ro, Cursor, Clay, Zipline, Groupme, Warby Parker, and Scopely.[9][2][10][11][12]

References

  1. Nicolette Tuono. A New York VC Spotlight: Adam Rothenberg Alley Watch, February 18, 2014, retrieved March 7, 2016^
  2. Nathan Allen. The top 20 investors behind MBA startups Poets & Quants, March 2, 2015, retrieved March 7, 2016^
  3. Ramp, a Brex and Amex rival, raises $25 million for a new corporate card Fortune, retrieved 2020-02-21^
  4. Jessica Kreps, Adam Rothenberg The New York Times, October 27, 2013, retrieved March 7, 2016^
  5. Investability of a startup: Interview with BoxGroup’s David Tisch Under 30 CEO, 2016, retrieved March 7, 2016^
  6. BoxGroup Closes Two Funds Totaling $165 Million Cooley^
  7. Tanya Benedicto Klich. VC 100: The top investors in early-stage startups Entrepreneur, February 19, 2015, retrieved March 7, 2016^
  8. Leo Schwartz. Exclusive: David Tisch’s BoxGroup raises $550 million across two new funds as venture firm crosses 16 years Fortune^
  9. How the quiet Adam Rothenberg become number two at hot startup incubator, TechStars NY Venture Beat, March 12, 2012, retrieved March 7, 2016^
  10. Joseph Keenan. Vial reels in $67M in series B fund raising; adds NEXT Oncology to network Fierce Biotech, 30 November 2022^
  11. Brian Gormley. General Catalyst Backs Clinical Trials Startup Vial Wall Street Journal, 30 November 2022^
  12. Chris Metinko. Exclusive: Zipline AI raises a $7M seed Axios^